Categories: Emilio Torres | Enes Aydemir | Farhad Hafezi | Larissa Paulasto | Léonard Kollros | Mark Hillen | News | Scientific article
ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.